ARA Warm Relief
Natural health product licensed in Canada
- Other names
- Warm Relief
- Licence holder
- ARA - Avanti Rx Analytics Inc.
- NPN or DIN-HM
- 80076202
- Status
- Inactive licence
- Licence date
- 20 March 2017
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (6E)-N-[(4-Hydroxy-3-méthoxyphényl)méthyl]-8-méthyl-6-nonenamide Source : Capsicum annuum - fruit | 0.025 Pour cent |
Non-medicinal ingredients
Bêta-caryophyllène, 1-p-menthén-8-ol, Bisabolol, Caryophyllène, bêta-Myrcène, 2(10)-pinène, Linalool, d-limonène
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 0.5 millilitre | 4 Tous les jours |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms worsen, or re-occur within a few days, discontinue use and consult a health care practitioner.
- Effets indésirables connus
Hypersensitivity, rashes and/or burning discomfort have been known to occur; in which case, discontinue use. Headache and redness have been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80076202
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.